CVS
CVS HEALTH Corp
NYSE · Healthcare · Medical - Healthcare Plans · US
$88.84
−1.58%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $1.60
- Revenue estimate
- $104.5B
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $2.58
- EPS estimate
- $1.87
- Revenue actual
- $106.1B
- Revenue estimate
- $100.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +24.2%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $115
- PT range
- $108 – $125
- Analysts
- 11
11 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $1.87 | $2.58 | Beat 37.97% | $106.1B |
| May 6, 2026 | $2.18 | $2.57 | Beat 17.89% | $100.4B |
| Oct 29, 2025 | $1.37 | $1.60 | Beat 16.79% | $102.9B |
| Jul 31, 2025 | $1.46 | $1.81 | Beat 23.97% | $98.9B |
| May 1, 2025 | $1.70 | $2.25 | Beat 32.35% | $94.6B |
| Feb 12, 2025 | $0.91 | $1.19 | Beat 30.20% | $97.7B |
| May 1, 2024 | $1.71 | $1.31 | Miss -23.39% | $88.4B |
| Feb 7, 2024 | $2.01 | $2.12 | Beat 5.53% | $93.8B |
| Nov 1, 2023 | $2.13 | $2.21 | Beat 3.80% | $89.8B |
| Aug 2, 2023 | $2.13 | $2.21 | Beat 3.95% | $88.9B |
| May 3, 2023 | $2.08 | $2.20 | Beat 6.02% | $85.3B |
| Feb 8, 2023 | $1.93 | $1.99 | Beat 3.32% | $83.8B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026